Objective: To examine the epidemiology of the tetM gene in Neisseria gonorrhoeae strains with high level resistance to tetracycline (TRNG) using a polymerase chain reaction (PCR) assay. Methods: A single tube PCR was developed which distinguishes between the American and Dutch variants of the tetM gene. Between 1988 and 1995, 518 strains of TRNG (tetracycline MIC >8 mg/l) were referred to the Gonococcus Reference Unit by other laboratories or isolated from routine swabs taken at local clinics. The strains were analysed for plasmid content, auxotype, serovar, and the tetM gene type. Travel details of the patients were determined by a questionnaire. Results: A PCR product was obtained from all TRNG examined. 387 TRNG strains produced a 778 bp PCR product (American type tetM) and 131 produced a 443 bp PCR product (Dutch type tetM). Infections acquired in the United Kingdom contributed 57% of the TRNG strains included in this study; 82% of these carried the American type of tetM. The number of UK acquired TRNG received by the GRU increased each year except 1993-from four strains received in 1990 to 92 in 1995. After the United Kingdom, Caribbean and African countries contributed most strains, with 56 and 60 TRNG acquired in each area respectively. All strains originating in Africa, except one from South Africa, contained the American type tetM. Infections caught in Nigeria and Kenya contributed most strains (15 and 14 respectively). The TRNG originating from Caribbean countries comprised 36% Dutch tetM type. Infections caught in Jamaica accounted for 82% of the Caribbean strains. All 35 TRNG strains originating in the Far East contained the Dutch type tetM. 25 of the Far East strains were also penicillinase producing (PPNG). Infections originating in Indonesia accounted for 49% of the Far East strains but these belonged to 12 diVerent auxotype/serovar combinations. A geographical variation in the type of penicillinase coding plasmids found in PPNG/TRNG was also detected. Conclusions: These data suggest that the Dutch type tetM may have originated in the Far East and the American type in the African continent. Subsequent spread has resulted in a heterogeneous distribution of TRNG types in other parts of the world. At completion of the survey the numbers of TRNG imported each year from the major overseas sources had reached a plateau while UK contracted TRNG continued to rise providing evidence for the establishment of endemic TRNG strains in the United Kingdom. (Sex Transm Inf 1999;75:60-66) 
Introduction
Infections caused by gonococci with high level plasmid mediated resistance to tetracycline (TRNG) were first recognised in the United Kingdom in 1987. 1 Isolations of TRNG have also been reported from the Netherlands, France, Spain, Canada, Africa, and Uruguay, [2] [3] [4] [5] [6] [7] following the original recognition of TRNG in the United States in 1985. 8 Subsequent epidemiological studies have suggested a worldwide distribution for TRNG strains. 9 10 High level tetracycline resistance (minimum inhibitory concentration (MIC) >8 mg/l) in gonococci is mediated by a tetM determinant carried on a 25.2 MDa conjugative plasmid. 11 The restriction endonuclease map of the 25.2 MDa conjugative plasmid from a TRNG strain imported from the United States has been found to diVer from a map derived from a strain isolated in the Netherlands. 12 These two types of tetM carrying conjugative plasmids were designated "American" and "Dutch" respectively. The latter had a restriction map similar to the 24.5 MDa conjugative plasmid found in tetracycline sensitive strains of N gonorrhoeae whereas the map of the American type suggested a diVerent origin. More recently the nucleotide sequences of the tetM genes from the American and Dutch conjugative plasmids have been determined and found to diVer significantly. 13 As tetracycline is a cheap drug it may still be used in some parts of the world to treat both gonorrhoea and chlamydia infection. 14 15 Laboratory tests to screen for resistance in gonococci have been described 11 14 16 ; however, a rapid test that simultaneously detects and types the gene responsible for tetracycline resistance may have a role in epidemiological studies of resistance. We have designed three oligonucleotide primers that will hybridise with the tetM gene in a polymerase chain reaction (PCR). The results presented here describe the use of these primers to detect and type the tetM gene in gonococci and, together with patient demographic data, describe the global distribution of the tetM gene.
Materials and methods

SOURCES OF N GONORRHOEAE STRAINS
The gonococci used in the study were collected between 1988 and 1995. The isolates were received for confirmation and further tests from laboratories around the United Kingdom or were isolated by the Gonococcus Reference Unit (GRU) from routine diagnostic specimens taken at two local genitourinary medicine clinics. The identity of strains was confirmed by Gram film, oxidase reaction, and the production of acid from glucose but not maltose or sucrose in cysteine trypticase agar. The Phadebact Monoclonal GC Test (Boule Diagnostics AB, Huddinge, Sweden) was also used to confirm the identity of strains and to provide a serogroup result for strains that were not serotyped.
The World Health Organisation (WHO) set of strains designated A to E and a TRNG strain kindly provided by Dr C A Ison, St Mary's Hospital Medical School, Paddington, London, were used as controls for the antimicrobial sensitivity tests.
The PCR reaction was validated using 20 strains of N gonorrhoeae, obtained from the culture collection of the GRU, carrying tetM conjugative plasmids with previously determined endonuclease restriction pattern type 12 and tetM type. 17 Twenty two gonococci with tetracycline MICs that were borderline for high level resistance (MIC 8 mg/l) but did not contain the 25.2 MDa plasmid and 16 strains of gonococci known to be carrying 24.5 MDa conjugative plasmids in combination with penicillinase plasmids (tetracycline MIC range 1-4 mg/l) were also included. These two sets of strains were also obtained from the culture collection of the GRU. The borderline tetracycline resistant strains were originally isolated by laboratories in 12 cities in the United Kingdom and the conjugative plasmid carrying strains were isolated by laboratories in 10 cities.
ANTIBIOTIC SUSCEPTIBILITY TESTING
The agar dilution method was used. Appropriate dilutions of tetracycline were incorporated into Blood Agar Base No 2 (Difco) supplemented with 5% horse blood. A multipoint inoculator was used to deliver approximately 10 4 colony forming units (cfu) of each strain onto the plates. Endpoints were read as complete inhibition of growth after 18 hours at 37°C in 5% carbon dioxide. WHO strains A-E and the control TRNG were included in each batch of organisms tested to ensure day to day reproducibility.
Penicillinase production was detected using a modification of the method of Hodge et al 18 essentially utilising protection of the "Oxford" strain of Staphylococcus aureus inoculated with the test strain onto heated blood agar containing 1 mg/l ampicillin.
PLASMID DETECTION
Gonococci with a MIC of tetracycline of >16 mg/l, and appropriate control strains were subcultured onto New York City agar. Growth was harvested from the plate after overnight incubation. Plasmid DNA was purified using a modification of the Birnboim and Doly method, 19 separated by electrophoresis through 1% agarose gel and visualised by ultraviolet fluorescence after ethidium bromide staining. The GenBank accession number for the tetM gene sequence for pOZ100 is L12241 and that for pOZ101 is L12242. The prepared DNA (2 µl) was added, the reaction mixture overlaid with two drops of paraYn oil and transferred to the thermal cycler (Omnigene, Hybaid, UK). The reaction mixture was incubated at 94°C for 3 minutes and then 30 cycles of PCR were performed consisting of denaturing for 20 seconds at 94°C, annealing for 1 minute at 55°C and extension for 1 minute 30 seconds at 72°C. In the final cycle there was a step of 7 minutes at 72°C to complete extension. The expected product sizes of this PCR assay were 778 and 443 base pairs from the American and Dutch types of tetM respectively.
A control "Dutch" tetM carrying strain (GR7698), a control "American" tetM strain (GR7646), and a negative control strain (SB5) carrying the 24.5 MDa conjugative plasmid were included in each PCR experiment. PCR products were analysed by electrophoresis in 1% w/v agarose and visualised by ultraviolet fluorescence after ethidium bromide staining.
To confirm the identity of the PCR amplicons, the PCR products from 12 gonococcal isolates (three controls and three test strains of each tetM type) were digested with Taq-1 endonuclease and the restriction products visualised after electrophoresis on 10% polyacrylamide gel. The restriction product sizes predicted were distinct for amplicons from the American and Dutch type tetM types even if a 443 bp (Dutch type) product were generated from an American type tetM by mispriming.
AUXOTYPING
The defined medium of Copley and Egglestone 20 was used to test for nutritional requirement for proline, arginine, hypoxanthine, and uracil. In addition, the ability of ornithine to replace a requirement for arginine was tested.
SEROTYPING
Monoclonal antibodies raised against the major outer membrane protein I of N gonorrhoeae produced by Genetic Systems (GS) (supplied by Syva, Palo Alto, CA, USA) were used to serotype strains. Six monoclonal antibodies were specific for protein IA strains and six were specific for protein IB strains. Test strains were suspended in PBS and boiled for 10 minutes, after cooling a drop of this was added to an equal volume of each monoclonal antibody coated Staphylococcus aureus suspension on a glass slide. The co-agglutination reaction pattern with each panel was read after gentle rocking for 2 minutes and the nomenclature scheme of Knapp et al 21 was used to determine the serovar.
DEMOGRAPHIC DATA
A questionnaire was issued to the referring laboratory or clinic with the laboratory report of each tetracycline resistant gonococcus. This allowed information to be gathered on the travel history of the patient and other demographic information.
Results
The PCR assay gave a product consistent with the predicted size of 778 bp from the American type and 443 bp from the Dutch type of tetM (fig 1) . The 778 bp product was obtained from all 12 strains of N gonorrhoeae known to be carrying American tetM type, and a 443 bp product was obtained from all eight strains of N gonorrhoeae carrying Dutch tetM type (table  1) .
Restriction fragment analysis using Taq-1 was performed on the PCR amplicons from 12 gonococcal isolates (three controls and three test strains of each tetM type). Products of the predicted sizes (74, 130, and 572 bp for the 778 bp amplicons and 126, 130, and 185 bp for the 443 bp amplicons: predicted 2 bp products from both types were not visualised) were found in preparations made from all strains.
The specificity of the PCR assay was tested using DNA preparations from 16 tetracycline sensitive penicillinase producing strains carrying the 24.5 MDa conjugative plasmid (table 2) and 22 strains with tetracycline MICs of 8 mg/l. No product of any size was detected in the PCR assay from these two groups of strains.
In all, 518 strains of TRNG isolated in the United Kingdom but originating from infections acquired in 39 countries worldwide as well as the United Kingdom, were tested in the tetM PCR assay. A total of 387 TRNG strains produced 778 bp PCR products (American Penicillinase production was detected in 12 (71%) of the 17 Jamaican TRNG carrying the Dutch tetM type. All PPNG/TRNG acquired in Jamaica carried the 3.2MDa lactamase plasmid. Jamaican TRNG carrying the American tetM type belonged to 10 diVerent A/S types although 11 (38%) were non-requiring/ IB2 and 10 of the 11 were PPNG. Jamaican TRNG carrying the Dutch tetM type belonged to nine diVerent A/S types, the most frequent (table 3) . Of the 17 strains originating from Indonesia 14 (82%) were PPNG, these belonged to 12 diVerent A/S combinations; however, eight were the nonrequiring auxotype and of these four were the IA6 and three the IA4 serovar.
Discussion
In this study we have reported the development of a PCR technique which enables the simultaneous detection and typing of the tetM gene in gonococci. Complete agreement of tetM type was achieved with 20 strains of TRNG that had been examined using a restriction fragment polymorphism method reported by GascoyneBinzi et al. 17 The PCR method reported here was applied to all 518 tetracycline resistant gonococci referred to the Gonococcus Reference Unit between 1988 and 1995. A PCR product was obtained from all strains and the product size always corresponded to that obtained from either the Dutch (443 bp) or the American (778 bp) type of tetM gene.
Two other PCR based methods for the detection and typing of the tetracycline resistance genotype in gonococci have been described. Ison et al described a PCR-RFLP assay in which the tetM gene is amplified by PCR but requires endonuclease digestion to discriminate between the American and Dutch types. 14 Xia et al describe a diVerential PCR assay which does not require post-amplification restriction analysis. 22 However the deletion responsible for the diVerent sizes of products in this assay is downstream of the tetM gene and therefore the heterogeneity detected may not be reflected in the tetM nucleotide sequence. To facilitate this survey of the geographical distribution of tetM determinants we developed a simple single tube PCR assay which was specific to the tetM gene and did not require restriction of products. This assay could also be used to detect and characterise the tetM gene if it became integrated into the chromosome, as has been reported in non-pathogenic Neisseria 22 but not, as yet, gonococci.
The tetM gene detection and typing data, together with collected travel and contact information, was used to describe the global distribution of TRNG as sampled by travellers diagnosed and treated for gonorrhoea in the United Kingdom. Although TRNG first appeared in the United Kingdom in 1987 1 our data suggest that they did not become established until 1990. After this date there has been a steady rise in the numbers of TRNG infections contracted in the United Kingdom; four strains were received by the GRU in 1990 and by 1995 the number had risen to 92. Over the period of study 82% of UK acquired TRNG contained the American type tetM gene. Overall, 75% of TRNG received by the GRU contained the American type tetM gene. The rise in incidence in the United Kingdom provides evidence for persistence of TRNG in the United Kingdom as the numbers of TRNG imported each year from the major overseas areas (Africa, the Caribbean, and the Far East) have remained approximately constant from 1991 to 1995. The establishment of TRNG strains in the United Kingdom was predicted as early as 1990 as a likely result of the use of tetracyclines to treat chlamydia infections and pelvic inflammatory disease. 23 All TRNG strains isolated from patients infected in South East Asia were found to carry the Dutch tetM gene. All penicillinase producing TRNG originating in this region carried the 4.4 MDa plasmid except one previously reported 24 isolate from the Philippines which possessed a 3.0 MDa plasmid. This strain also demonstrated high level resistance to ciprofloxacin (MIC 16 mg/l). Other studies 25 26 have detected 3.2 MDa plasmids in PPNG isolated in the Far East but none was also TRNG. The type of tetM gene has been reported in one other study of Asian TRNG; of three strains isolated in Japan, one American type was found in an infection originating in Japan during 1985, and two Dutch tetM strains were found, one originating in Thailand in 1991 and the other was of unknown origin. 27 The WHO Western Pacific Region Gonococcal Antimicrobial Surveillance Programme (GASP) has revealed considerable diVerences in incidence in TRNG, isolated between 1992 and 1994, across this region, ranging from 0% in Japan to 100% in the Philippines. 28 Only Vietnam showed a significant rise in incidence during the period of study. The GASP study did not include Indonesia where most of the South East Asian TRNG originated from in the present study. However, a study of gonococci isolated during 1992-3 from female Indonesian sex workers revealed 98% of strains were TRNG. 29 Most of the TRNG isolated from these patients belonged to the proline requiring/IA8 A/S class in contrast with the strains in the present study where considerable heterogeneity was found. In a smaller study in the Philippines 26 most (5/6) TRNG or TRNG/ PPNG were the arginine requiring/IA4 A/S class although there was heterogeneity among other gonococci in the study.
The emergence and spread of TRNG in west and central African countries is well documented. 6 15 30 31 In contrast, no TRNG were detected during 1990-3 in a study of isolates made from symptomatic men conducted in Durban, South Africa, 32 or in Carltonville, South Africa between 1989 and 1990. 33 In most studies few data exist about the genetic basis of the resistance other than plasmid size, although in isolates from Zaire the presence of tetM was confirmed by DNA hybridisation and the plasmid was demonstrated to be of the American type. 6 In the present study, travellers visiting Kenya and Nigeria contributed most (29/60) of the TRNG infections originating in Africa. All TRNG strains from east, west, and central Africa contained the American type of tetM. All TRNG strains acquired in southern Africa except one from South Africa were also of the American type. A recent study of antibiotic resistant gonococci isolated in southern Africa did not detect TRNG in 55 isolates from South Africa but did find 11 TRNG among 19 isolates from Namibia and Botswana; all 11 carried the American type of tetM gene. 34 The high prevalence of proline requiring and IA6 serovar tetracycline resistant strains in African countries 6 15 30 was confirmed in the present study. The TRNG originating from the two most common sources, Kenya and Nigeria, comprised 57% and 33%, respectively, of this A/S class although three other A/S classes were found in Kenyan strains and five in Nigerian strains.
The island of Jamaica provided the first high level tetracycline resistant isolate of N gonorrhoeae in the present study, although three other isolates of unknown origin were also received in 1988. Over the period of the study Jamaica accounted for 82% of strains originating from the Caribbean region. In contrast with Africa and the Far East the TRNG originating from the Caribbean were of a mixed tetM type with 65% American type. A previous study has documented a high rate (69%) of TRNG among Jamaican gonococci isolated between October 1990 and March 1991. 35 As in the current study, all PPNG among the Jamaican study isolates carried the 3.2 MDa lactamase plasmid although a previous survey of Jamaican strains isolated in 1983-4 had detected six strains out of 20 PPNG that carried the Asian (4.4 MDa) plasmid. 36 The results obtained from a survey of plasmid mediated antibiotic resistance in gonococci in Jamaica 35 indicated there was heterogeneity among tetracycline resistant strains. The TRNG and TRNG/ PPNG in this study were found to belong to eight and 11 A/S classes respectively. This was confirmed by the present study where 10 A/S classes were found in strains carrying the American tetM type and nine A/S classes among the strains carrying the Dutch type.
The data presented here provide evidence for a variation in the global distribution of variants of the tetM gene. The distribution suggests that the Dutch type of tetM may have originated in the Far East, possibly in Indonesia, and that the American type may have originated in the equatorial regions of the African continent. International travel has since distributed both types of tetM to other parts of the world and heterogeneity of auxotype/serovar class would indicate that interstrain distribution of the tetM gene has also taken place. At completion of the survey the numbers of TRNG imported each year from the major overseas sources had reached a plateau while UK contracted TRNG continued to rise, providing evidence for the establishment of endemic TRNG strains in the United Kingdom.
